These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 21330855

  • 21. [Dobutamine, dopamine, and other catecholamine-like substances for myocardial infarct].
    Machii K.
    Nihon Rinsho; 1983 Dec; 41(12):2685-90. PubMed ID: 6674555
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Vasoactive drug support in septic shock.
    Dries DJ.
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract] [Full Text] [Related]

  • 28. Norepinephrine or just more epinephrine: Which is the best vasopressor for post-arrest shock?
    Johnson NJ, Moskowitz A.
    Resuscitation; 2024 May; 198():110215. PubMed ID: 38609064
    [No Abstract] [Full Text] [Related]

  • 29. Cardiogenic shock and its current treatment.
    Willerson JT.
    Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacologic support in cardiogenic shock.
    Rude RE.
    Adv Shock Res; 1983 Apr; 10():35-49. PubMed ID: 6349299
    [Abstract] [Full Text] [Related]

  • 31. The medical treatment of cardiogenic shock: cardiovascular drugs.
    De Backer D, Arias Ortiz J, Levy B.
    Curr Opin Crit Care; 2021 Aug 01; 27(4):426-432. PubMed ID: 33797431
    [Abstract] [Full Text] [Related]

  • 32. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
    Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Mallédant Y.
    Clin Pharmacol Ther; 2002 May 01; 71(5):381-8. PubMed ID: 12011824
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of catecholamines in acute myocardial infarction.
    Dixon DW, Loeb HS, Gunnar RM.
    Herz; 1979 Oct 01; 4(5):385-96. PubMed ID: 391685
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.
    Pei XB, Ma PL, Li JG, Du ZH, Zhou Q, Lu ZH, Yun L, Hu B.
    Chin Med J (Engl); 2015 Apr 20; 128(8):1014-20. PubMed ID: 25881592
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.